Order a Consult

Consult KDL dermatopathologists for diseases including problematic pigmented lesions, immunobullous disorders, unusual cutaneous neoplasms, and inflammatory dermatoses. We give each case the concentration it requires, and the KDL Pathologist who signs out your case will be available by phone to discuss your case.

Physician (required)

Email (required)


Physician Chart Number

Patient Name (required)

Patient DOB (required)

Patient Phone


Please input this code is the box below:



News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all metastatic melanomas. More

Contact Us

facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.